EA202090173A1 - Стабильные каннабиноидные композиции - Google Patents

Стабильные каннабиноидные композиции

Info

Publication number
EA202090173A1
EA202090173A1 EA202090173A EA202090173A EA202090173A1 EA 202090173 A1 EA202090173 A1 EA 202090173A1 EA 202090173 A EA202090173 A EA 202090173A EA 202090173 A EA202090173 A EA 202090173A EA 202090173 A1 EA202090173 A1 EA 202090173A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cannabinoid
cannabinoid compositions
stable cannabinoid
poloxamer
stable
Prior art date
Application number
EA202090173A
Other languages
English (en)
Inventor
Ильзе Кнёллер
Томас Зовик
Original Assignee
Сино-Джерман М Энд А Сервиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сино-Джерман М Энд А Сервиз Гмбх filed Critical Сино-Джерман М Энд А Сервиз Гмбх
Publication of EA202090173A1 publication Critical patent/EA202090173A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Композиция, содержащая каннабиноид, в частности фитоканнабиноид или синтетический каннабиноид, где каннабиноид стабилизирован против окисления и/или фотохимического разложения, отличающаяся тем, что композиция содержит мицеллярный раствор мицелл на основе полоксамера в водном растворе, где мицеллы полоксамера инкапсулируют каннабиноид.
EA202090173A 2017-07-07 2018-07-06 Стабильные каннабиноидные композиции EA202090173A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17180383.6A EP3424494A1 (en) 2017-07-07 2017-07-07 Stable cannabinoid compositions
PCT/EP2018/068451 WO2019008178A1 (en) 2017-07-07 2018-07-06 STABLE CANNABINOID COMPOSITIONS

Publications (1)

Publication Number Publication Date
EA202090173A1 true EA202090173A1 (ru) 2020-06-04

Family

ID=59315426

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090173A EA202090173A1 (ru) 2017-07-07 2018-07-06 Стабильные каннабиноидные композиции

Country Status (9)

Country Link
US (1) US20200222360A1 (ru)
EP (2) EP3424494A1 (ru)
JP (1) JP7336438B2 (ru)
KR (1) KR20200040756A (ru)
CN (1) CN111225661A (ru)
CA (1) CA3076684A1 (ru)
EA (1) EA202090173A1 (ru)
IL (1) IL271891B2 (ru)
WO (1) WO2019008178A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220183999A1 (en) * 2019-04-05 2022-06-16 Sorrento Therapeutics, Inc. Cannabidiol Pharmaceutical Compositions
CN112915121A (zh) 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种***素纳米胶束制剂及其制备方法
WO2021138597A1 (en) * 2019-12-31 2021-07-08 Soluscience, Llc Water-soluble cannabinoid formulations and methods of their making
US20210353554A1 (en) * 2020-05-18 2021-11-18 Max Biology Co. Ltd. Lipid-polymer compositions and methods of use
US20230346808A1 (en) * 2020-08-31 2023-11-02 PreveCeutical Medical Inc. Cannabinoid formulations and methods of use
CN114748434B (zh) * 2020-12-29 2023-06-16 汉义生物科技（北京）有限公司 一种***素泡腾片及其制备方法
CN114748429A (zh) * 2020-12-29 2022-07-15 汉义生物科技（北京）有限公司 一种水溶性***素制剂及其制备方法
WO2022187295A1 (en) * 2021-03-02 2022-09-09 Acid Neutral Alkaline Laboratory Poloxamer compositions and beverages
CN113197852B (zh) * 2021-04-20 2022-12-09 上海应用技术大学 ***二酚纳米胶束制剂及其制备方法
EP4275694A1 (de) 2022-05-13 2023-11-15 Solmic Biotech GmbH Verwendung von solubilisaten in erzeugnissen zur topischen anwendung
DE202022000150U1 (de) 2022-01-20 2022-07-07 Solmic Bio Tech Gmbh Maske für medizinische oder kosmetische Zwecke mit mizellierten Extrakten
WO2023139101A1 (de) 2022-01-20 2023-07-27 Solmic Biotech GmbH Maske für medizinische oder kosmetische zwecke mit mizellierten extrakten

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500368A (ja) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
WO2007104173A2 (de) 2006-03-10 2007-09-20 Laboswiss Ag Verfahren zum solubilisieren, dispergieren und stabilisieren von stoffen, nach dem verfahren hergestellte erzeugnisse sowie die verwendung derselben
EP2046290A4 (en) * 2006-08-04 2011-08-17 Insys Therapeutics Inc AQUEOUS DRONABINOL FORMULATIONS
US7435846B2 (en) * 2006-08-18 2008-10-14 Industrial Organica, S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
ES2622582T3 (es) * 2008-10-31 2017-07-06 University Of Mississippi Proceso para la preparación de ésteres de delta-9-THC-aminoácido
CA2780486C (en) * 2009-11-10 2018-01-02 MyCell Holdings Limited Stabilized formulations of fatty acids
US8808734B2 (en) 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
WO2014165672A1 (en) * 2013-04-06 2014-10-09 Igdrasol, Inc. Nanoparticle therapeutic agents, their formulations, and methods of their use
EP3028721A1 (en) * 2014-12-05 2016-06-08 Exchange Imaging Technologies GmbH Nanoparticle formulation having reverse-thermal gelation properties for injection
CN105055368A (zh) * 2015-09-23 2015-11-18 湖北雅仕达生物技术有限公司 促进胃肠道吸收虾青素的口服制品及制备方法
US20170119660A1 (en) * 2015-10-29 2017-05-04 Solubest Ltd Pharmaceutical compositions for transmucosal delivery

Also Published As

Publication number Publication date
AU2018296678A1 (en) 2020-02-20
EP3424494A1 (en) 2019-01-09
US20200222360A1 (en) 2020-07-16
CN111225661A (zh) 2020-06-02
KR20200040756A (ko) 2020-04-20
CA3076684A1 (en) 2019-01-10
IL271891B2 (en) 2023-07-01
IL271891B1 (en) 2023-03-01
JP7336438B2 (ja) 2023-08-31
JP2020527169A (ja) 2020-09-03
EP3675824A1 (en) 2020-07-08
IL271891A (en) 2020-02-27
WO2019008178A1 (en) 2019-01-10

Similar Documents

Publication Publication Date Title
EA202090173A1 (ru) Стабильные каннабиноидные композиции
EA202090177A1 (ru) Стабильные каннабиноидные композиции
MX2017013590A (es) Administracion de agente anticaspa soluble en surfactante.
EA201891171A1 (ru) Стабильные композиции с инокулянтом и способы их получения
AR104725A1 (es) Composiciones surfactantes y detergentes que contienen glicerina etoxilada
EA201991798A1 (ru) Стабильные при хранении составы
EA201892822A1 (ru) Новые антибактериальные соединения
SA519400913B1 (ar) تركيبة موضعية لتعزيز إلتئام الجروح
EA201791749A1 (ru) Инкапсуляция высокоэффективных активных агентов
AR101581A1 (es) Composición de colutorio
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
MX2017013278A (es) Odorante osmanthus.
EA032472B9 (ru) Композиция для укладки волос
EA201990483A1 (ru) Композиции, содержащие конкретные поверхностно-активные вещества и высокие содержания глицерина
EA202091456A1 (ru) Мононитрат моноацетата пропандиола
AR109350A1 (es) Composición para el cuidado personal
AR108149A1 (es) Producto para el cuidado bucal
MA40965A (fr) Préparations contenant de l'acide ascorbique, de l'ubidécarénone et un mélange émulsifiant
FR3062793B1 (fr) Utilisation de 2,5-dicetopiperazines en tant qu'agents cosmetiques
PL417588A1 (pl) Mieszanina antyutleniająca
UA120068C2 (uk) Фунгіцидна композиція
DE202017004227U1 (de) Alkoholfreie Getränke mit erotisierenden Wirkstoffen
TR201714964A2 (tr) Efervesan tablet formülasyonları.
ITUA20163937A1 (it) Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.
TH174178B (th) ที่ใส่ของ